Abstract：Objective To study the clinical features of sleep-disordered breathing (SDB) in children with neuromuscular disease (NMD). Methods A retrospective analysis was performed on the medical data of 18 children who were diagnosed with NMD and underwent polysomnography (PSG) (NMD group). Eleven children without NMD who had abnormal sleeping habit and normal sleep structure on PSG were enrolled as the control group. The two groups were compared in terms of the daily and nocturnal symptoms of SDB, incidence rate of obstructive sleep apnea (OSA), pulmonary function, end-tidal partial pressure of carbon dioxide (PetCO2), features of sleep structure, and sleep respiratory events. Results In the NMD group, 16 children (89%) had related daily and nocturnal symptoms of SDB, and the youngest age was 1 year at the onset of such symptoms. Compared with the control group, the NMD group had significant reductions in total sleep time and sleep efficiency (P < 0.05), a significant reduction in the proportion of rapid eye movement (REM) sleep (P < 0.05), significant increases in obstructive apnea and hypopnea events (P < 0.05) and oxygen reduction events during REM sleep (P < 0.05), and a significant reduction in blood oxygen saturation during REM sleep (P < 0.05). In the NMD group, 17 children (94%) were diagnosed with OSA, and all children had normal lung function and PetCO2. Conclusions There is a high proportion of children with SDB among the children with NMD, and SDB can be observed in the early stage of NMD, which results in the damage of sleep structure and the reduction in sleep efficiency. Respiratory events are mainly obstructive events, and oxygen reduction events are mainly observed during REM sleep.
YANG Qin,BAO Yan-Min,LU Xin-Guo et al. Clinical features of sleep-disordered breathing in children with neuromuscular disease[J]. CJCP, 2021, 23(2): 158-163.
Shieh PB. Advances in the genetic testing of neuromuscular diseases[J]. Neurol Clin, 2020, 38(3):519-528.
[2]
Albdewi MA, Liistro G, El Tahry R. Sleep-disordered breathing in patients with neuromuscular disease[J]. Sleep Breath, 2018, 22(2):277-286.
[3]
Suresh S, Wales P, Dakin C, et al. Sleep-related breathing disorder in Duchenne muscular dystrophy:disease spectrum in the paediatric population[J]. J Paediatr Child Health, 2005, 41(9-10):500-503.
[4]
Al-Shamrani A, Alharbi AS. Diagnosis and management of childhood sleep-disordered breathing. Clinical approach[J]. Saudi Med J, 2020, 41(9):916-929.
[5]
Polat M, Sakinci O, Ersoy B, et al. Assessment of sleep-related breathing disorders in patients with Duchenne muscular dystrophy[J]. J Clin Med Res, 2012, 4(5):332-337.
Sheikh O, Yokota T. Advances in genetic characterization and genotype-phenotype correlation of Duchenne and Becker muscular dystrophy in the personalized medicine era[J]. J Pers Med, 2020, 10(3):111.
[8]
Atwal PS, Midei M, Adams D, et al. The Infantile Neuroaxonal Dystrophy Rating Scale (INAD-RS)[J]. Orphanet J Rare Dis, 2020, 15(1):195.
[9]
Prior TW, Bayrak-Toydemir P, Lynnes TC, et al. Characterization of reference materials for spinal muscular atrophy genetic testing:a genetic testing reference materials coordination program collaborative project[J]. J Mol Diagn, 2021, 23(1):103-110.
[10]
Verhulst SL, Schrauwen N, Haentjens D, et al. Reference values for sleep-related respiratory variables in asymptomatic European children and adolescents[J]. Pediatr Pulmonol, 2007, 42(2):159-167.
[11]
Traeger N, Schultz B, Pollock AN, et al. Polysomnographic values in children 2-9 years old:additional data and review of the literature[J]. Pediatr Pulmonol, 2005, 40(1):22-30.
Gurbani N, Pascoe JE, Katz S, et al. Sleep disordered breathing:assessment and therapy in the age of emerging neuromuscular therapies[J]. Pediatr Pulmonol, 2020. DOI:10.1002/ppul.24988. Online ahead of print.
[14]
Hull J, Aniapravan R, Chan E, et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness[J]. Thorax, 2012, 67(Suppl 1):i1-i40.
[15]
Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep:update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine[J]. J Clin Sleep Med, 2012, 8(5):597-619.
Aboussouan LS, Mireles-Cabodevila E. Sleep-disordered breathing in neuromuscular disease:diagnostic and therapeutic challenges[J]. Chest, 2017, 152(4):880-892.
[18]
Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2:respiratory, cardiac, bone health, and orthopaedic management[J]. Lancet Neurol, 2018, 17(4):347-361.
[19]
Nozoe KT, Moreira GA, Tolino JR, et al. The sleep characteristics in symptomatic patients with Duchenne muscular dystrophy[J]. Sleep Breath, 2015, 19(3):1051-1056.
[20]
Boentert M. Sleep disturbances in patients with amyotrophic lateral sclerosis:current perspectives[J]. Nat Sci Sleep, 2019, 11:97-111.
[21]
Jacobs TL, Brown DL, Baek J, et al. Trial of early noninvasive ventilation for ALS:a pilot placebo-controlled study[J]. Neurology, 2016, 87(18):1878-1883.
[22]
Hoque R. Sleep-disordered breathing in Duchenne muscular dystrophy:an assessment of the literature[J]. J Clin Sleep Med, 2016, 12(6):905-911.
[23]
Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2:implementation of multidisciplinary care[J]. Lancet Neurol, 2010, 9(2):177-189.
[24]
Hussain SN, Cornachione AS, Guichon C, et al. Prolonged controlled mechanical ventilation in humans triggers myofibrillar contractile dysfunction and myofilament protein loss in the diaphragm[J]. Thorax, 2016, 71(5):436-445.
[25]
Bernardes Neto SCG, Torres R, Lima Í, et al. Weaning from mechanical ventilation in people with neuromuscular disease:protocol for a systematic review[J]. BMJ Open, 2019, 9(11):e029890.
[26]
Lechtzin N, Wiener CM, Shade DM, et al. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis[J]. Chest, 2002, 121(2):436-442.
